Spandidos Publications style
Paulides M, Stöhr W, Bielack S, Jürgens H, Koscielniak E, Klingebiel T, Zimmermann R, Stachel D, Langer T, Beck J, Beck J, et al: Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment
in paediatric sarcoma patients: A report from the Late Effects Surveillance System. Oncol Rep 15: 687-691, 2006.
APA
Paulides, M., Stöhr, W., Bielack, S., Jürgens, H., Koscielniak, E., Klingebiel, T. ... Beck, J. (2006). Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment
in paediatric sarcoma patients: A report from the Late Effects Surveillance System. Oncology Reports, 15, 687-691. https://doi.org/10.3892/or.15.3.687
MLA
Paulides, M., Stöhr, W., Bielack, S., Jürgens, H., Koscielniak, E., Klingebiel, T., Zimmermann, R., Stachel, D., Langer, T., Beck, J."Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment
in paediatric sarcoma patients: A report from the Late Effects Surveillance System". Oncology Reports 15.3 (2006): 687-691.
Chicago
Paulides, M., Stöhr, W., Bielack, S., Jürgens, H., Koscielniak, E., Klingebiel, T., Zimmermann, R., Stachel, D., Langer, T., Beck, J."Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment
in paediatric sarcoma patients: A report from the Late Effects Surveillance System". Oncology Reports 15, no. 3 (2006): 687-691. https://doi.org/10.3892/or.15.3.687
